What is KMTS's price / sales?

KMTS (KMTS) reported price / sales of 17.2× in Q4 2025.

What does price / sales mean?

Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

KMTS KMTS Price / sales

Price / sales at other companies

AbbottABT

4×-1.5×

Boston ScientificBSX

4.5×-4.0×

MedtronicMDT

2.9×-0.4×

iRhythm Holdings, Inc. IRTC

4.8×-0.5×

Merit Medical SystemsMMSI

2.7×-1.8×

HaemoneticsHAE

2×-0.4×

Other financials

Income statement

See full

Revenue$24.6M+62.7%

Gross profit$12.9M+97.1%

Operating income-$34.8M-68.8%

Net income-$34.2M-58.8%

EPS (diluted)-$0.61+51.2%

Balance sheet

See full

Cash & equivalents$291.3M+436%

Total debt$43.8M—

Total assets$379.3M—

Cash flow

See full

Operating cash flow-$18.4M-2.1%

CapEx$9.8M+141%

Free cash flow-$28.2M-27.7%

Valuation

See full

Market cap$1.29B+67.0%

Enterprise value$1.04B—

Profitability

See full

Gross margin48.8%+15.1pp

Operating margin-171.5%+12.9pp

Net margin-173%+0.8pp

FCF margin-142.9%-25.3pp

Returns & leverage

See full

Current ratio7.3×—

Where this comes from

Calculated from KMTS’s reported figures.

market cap/total revenue=17.2×

Based on the most recent quarter.

The official record: KMTS’s 10-Q, filed March 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about KMTS's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is KMTS's price / sales?: KMTS (KMTS) reported price / sales of 17.2× in Q4 2025.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.